Over the last ten years, global R&D spend has been steadily increasing, as has R&D spend per new product. Shareholders, anxious to see improved returns are putting ever greater pressure on pharmaceutical businesses to deliver superior earnings. Innovation is widely seen as holding the key, and lies at the heart of a new value paradigm within the industry. But how precisely do you measure innovation and the ROI it generates? What enables the pharmaceutical industry's innovation leaders to outscore their competitors? What are the drivers of innovation and how should they be exploited to plug gaps in the R&D pipeline and restore or improve earnings growth. These are tough questions, but you'll find the answers in Pharmaceutical Innovation: An analysis of leading companies and strategies, a brand new report from Business Insights.
ISBN 1-84296-204-3
Published: July 2002 - Global. |
